Scott Simon,
Professor of Biomedical Engineering,
University of California-Davis
An Established Investigator of the American Heart Association, Professor Simon's work on chronic inflammation focuses on structure-function studies of integrin and selectin receptors and vascular dysfunction during atherosclerosis. His laboratory was the first to discover the signaling functions of L-selectin and E-selectin. More recently, his group has developed novel microfluidic vascular mimetic lab-on-a-chip systems that provide real time imaging of force and molecular dynamics in leukocyte-endothelial interactions under defined shear stress. A recently funded project on atherogenesis aims to develop artery-on-a-chip devices to gauge the inflammatory potential of native lipoproteins and molecular events underlying monocyte recruitment to endothelium conditioned with lipids collected from normal and metabolic syndrome subjects. These approaches provide low cost, real time tools to study the tissue level consequences and biomarkers to assess disease progression. Another funded project with the Krubitzer laboratory in the Center for Neuroscience applies microfluidic thermal regulators that were developed to reversibly cooling and deactivate specific areas of the neocortex. The goal of these studies is to examine changes in receptive field size and location for neurons during and after cooling posterior parietal and motor/premotor cortex.
Artery-on-a-Chip Analysis of Cardiovascular Disease
Wednesday, 30 September 2015 at 09:00
Add to Calendar ▼2015-09-30 09:00:002015-09-30 10:00:00Europe/LondonArtery-on-a-Chip Analysis of Cardiovascular DiseaseLab-on-a-Chip, Microfluidics and Microarrays World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Monocyte activation and adhesion to inflamed endothelium is an obligate step in the initiation of atherosclerosis. Despite the accepted paradigm of atherosclerosis as an inflammatory disease, population-wide studies that correlate established biomarkers in blood (e.g., chemokines, myeloperoxidase, c-reactive protein) with the progression of coronary artery disease are lacking. In particular, there are no personalized quantitative measures of activation at the level of the participating immune and vascular cells that provide predictive power for the occurrence of acute myocardial infarction. We will introduce an artery-on-a-chip device that provides a measure of monocyte and endothelial inflammatory activation. These cell based parameters correlate better than established biomarkers with the risk of cardiovascular events in patients.
Add to Calendar ▼2015-09-28 00:00:002015-09-30 00:00:00Europe/LondonLab-on-a-Chip, Microfluidics and Microarrays World CongressLab-on-a-Chip, Microfluidics and Microarrays World Congress in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com